BioStock: PolarCool boosted by 5-year clinical study results

Medtech company PolarCool has developed PolarCap, a medical device that actively cools down the brain in the acute phase of an injury to decrease concussion symptoms. Results from a 5-year clinical study with the device have just been published in the Journal of Neurotrauma, and PolarCool’s CEO Erik Andersson stopped by the BioStock Studio to discuss the results.

Watch the interview with PolarCool's CEO Erik Andersson at biostock.se:

https://www.biostock.se/en/2022/10/polarcool-boosted-by-5-year-clinical-study-results/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/